Suppr超能文献

[制剂茴香酰化纤溶酶原链激酶激活剂复合物(APSAC)溶栓治疗对心肌梗死病程的影响]

[The effect of thrombolytic therapy with the preparation APSAC on the course of myocardial infarct].

作者信息

Urazgil'deeva S A, Aminieva Kh K, Varshavskiĭ S Iu

出版信息

Ter Arkh. 1994;66(9):41-5.

PMID:7992211
Abstract

To evaluate the influence of thrombolytic therapy (TT) on the course of acute myocardial infarction (AMI), a comparative analysis of clinical and pathological findings was conducted. The latter included post mortem examination of 35 myocardial samples from patients treated with APSAC in the acute phase of the infarction. The analysis indicated the predominance of cases with unfavourable coronary heart disease, severe myocardial damage and severe AMI complications in the group of the decreased patients. The following beneficial effects of TT were reported: relatively safe stromal and parenchymal myocardial components, earlier regeneration of the connective tissue. Late TT had a negative effect on MI because more hemorrhagic infarctions occurred. The combination of TT and myocardial repair modulators is proposed.

摘要

为评估溶栓治疗(TT)对急性心肌梗死(AMI)病程的影响,对临床和病理结果进行了对比分析。后者包括对35例在梗死急性期接受APSAC治疗患者的心肌样本进行尸检。分析表明,在病情恶化的患者组中,冠心病不良、严重心肌损伤和严重AMI并发症的病例占主导。报告了TT的以下有益效果:心肌基质和实质成分相对安全,结缔组织再生较早。晚期TT对心肌梗死有负面影响,因为出现了更多出血性梗死。建议将TT与心肌修复调节剂联合使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验